Franklin Resources
TGTX icon

Franklin Resources’s TG Therapeutics TGTX Stock Holding History

Franklin Resources’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79M Sell
68,952
-15,328
-18% -$627K ﹤0.01% 1741
2026
Q1 		$2.8M Sell
84,280
-2,407
-3% -$71.7K ﹤0.01% 1780
2025
Q4 		$2.58M Sell
86,687
-1,772
-2% -$57.9K ﹤0.01% 1676
2025
Q3 		$3.2M Sell
88,459
-2,928
-3% -$96.4K ﹤0.01% 1616
2025
Q2 		$3.29M Buy
91,387
+18,452
+25% +$687K ﹤0.01% 1529
2025
Q1 		$2.88M Sell
72,935
-24,603
-25% -$828K ﹤0.01% 1566
2024
Q4 		$2.94M Sell
97,538
-31,447
-24% -$902K ﹤0.01% 1583
2024
Q3 		$2.94M Buy
128,985
+4,756
+4% +$104K ﹤0.01% 1588
2024
Q2 		$2.21M Buy
124,229
+7,212
+6% +$115K ﹤0.01% 1659
2024
Q1 		$1.78M Buy
117,017
+52,091
+80% +$830K ﹤0.01% 1763
2023
Q4 		$1.11M Buy
64,926
+30,322
+88% +$352K ﹤0.01% 1611
2023
Q3 		$289K Sell
34,604
-35,810
-51% -$499K ﹤0.01% 2160
2023
Q2 		$1.75M Buy
+70,414
New +$1.82M ﹤0.01% 1457
2018
Q4 		– Sell
-1,892,978
Closed -$10.6M – 1523
2018
Q3 		$10.6M Sell
1,892,978
-391,499
-17% -$4.47M 0.01% 919
2018
Q2 		$30M Sell
2,284,477
-129,220
-5% -$1.78M 0.02% 662
2018
Q1 		$34.3M Sell
2,413,697
-43,718
-2% -$559K 0.02% 631
2017
Q4 		$20.2M Buy
2,457,415
+87,398
+4% +$764K 0.01% 788
2017
Q3 		$28.1M Buy
2,370,017
+30,851
+1% +$351K 0.01% 707
2017
Q2 		$23.5M Buy
2,339,166
+398,916
+21% +$4.47M 0.01% 750
2017
Q1 		$22.6M Buy
+1,940,250
New +$13.9M 0.01% 754

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Franklin Resources's TGTX Position: Q2 2026 in Review

Franklin Resources reduced its TG Therapeutics (TGTX) stake by 18% in Q2 2026, selling an estimated $627K and leaving 68,952 shares worth $3.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

Franklin Resources first reported a position in TGTX in Q1 2017 and has held it in 20 quarters since. The position peaked at $34.3M in Q1 2018. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Franklin Resources held 68,952 shares of TG Therapeutics worth $3.79M as of Q2 2026.
  • Franklin Resources sold 15,328 TG Therapeutics shares in Q2 2026, an estimated $627K.
  • TG Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1741 holding.
  • Franklin Resources first reported a position in TG Therapeutics in Q1 2017 and has held it in 20 quarters since.
  • Franklin Resources's TG Therapeutics position peaked at $34.3M in Q1 2018.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.